APGE logo

Apogee Therapeutics (APGE) Cash from operations

annual CFO:

-$171.17M-$96.41M(-128.96%)
December 31, 2024

Summary

  • As of today (June 18, 2025), APGE annual cash flow from operations is -$171.17 million, with the most recent change of -$96.41 million (-128.96%) on December 31, 2024.
  • During the last 3 years, APGE annual CFO has fallen by -$154.75 million (-942.03%).
  • APGE annual CFO is now -942.03% below its all-time high of -$16.43 million, reached on December 31, 2022.

Performance

APGE Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEcash flow metrics

quarterly CFO:

-$48.48M+$19.24M(+28.41%)
March 31, 2025

Summary

  • As of today (June 18, 2025), APGE quarterly cash flow from operations is -$48.48 million, with the most recent change of +$19.24 million (+28.41%) on March 31, 2025.
  • Over the past year, APGE quarterly CFO has dropped by -$16.84 million (-53.23%).
  • APGE quarterly CFO is now -359.19% below its all-time high of -$10.56 million, reached on March 31, 2023.

Performance

APGE quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEcash flow metrics

TTM CFO:

-$188.01M-$16.84M(-9.84%)
March 31, 2025

Summary

  • As of today (June 18, 2025), APGE TTM cash flow from operations is -$188.01 million, with the most recent change of -$16.84 million (-9.84%) on March 31, 2025.
  • Over the past year, APGE TTM CFO has dropped by -$92.17 million (-96.18%).
  • APGE TTM CFO is now -1680.95% below its all-time high of -$10.56 million, reached on March 31, 2023.

Performance

APGE TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPGEcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

APGE Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-129.0%-53.2%-96.2%
3 y3 years-942.0%--
5 y5 years-942.0%--

APGE Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-942.0%at low-359.2%+28.4%-1681.0%at low
5 y5-year-942.0%at low-359.2%+28.4%-1681.0%at low
alltimeall time-942.0%at low-359.2%+28.4%-1681.0%at low

APGE Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
-$48.48M(-28.4%)
-$188.01M(+9.8%)
Dec 2024
-$171.17M(+129.0%)
-$67.71M(+59.2%)
-$171.17M(+28.5%)
Sep 2024
-
-$42.52M(+45.1%)
-$133.21M(+20.5%)
Jun 2024
-
-$29.30M(-7.4%)
-$110.57M(+15.4%)
Mar 2024
-
-$31.64M(+6.3%)
-$95.84M(+28.2%)
DateAnnualQuarterlyTTM
Dec 2023
-$74.76M(+355.1%)
-$29.75M(+49.7%)
-$74.76M(+66.1%)
Sep 2023
-
-$19.88M(+36.4%)
-$45.01M(+79.1%)
Jun 2023
-
-$14.57M(+38.0%)
-$25.13M(+138.0%)
Mar 2023
-
-$10.56M
-$10.56M
Dec 2022
-$16.43M
-
-

FAQ

  • What is Apogee Therapeutics annual cash flow from operations?
  • What is the all time high annual CFO for Apogee Therapeutics?
  • What is Apogee Therapeutics annual CFO year-on-year change?
  • What is Apogee Therapeutics quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Apogee Therapeutics?
  • What is Apogee Therapeutics quarterly CFO year-on-year change?
  • What is Apogee Therapeutics TTM cash flow from operations?
  • What is the all time high TTM CFO for Apogee Therapeutics?
  • What is Apogee Therapeutics TTM CFO year-on-year change?

What is Apogee Therapeutics annual cash flow from operations?

The current annual CFO of APGE is -$171.17M

What is the all time high annual CFO for Apogee Therapeutics?

Apogee Therapeutics all-time high annual cash flow from operations is -$16.43M

What is Apogee Therapeutics annual CFO year-on-year change?

Over the past year, APGE annual cash flow from operations has changed by -$96.41M (-128.96%)

What is Apogee Therapeutics quarterly cash flow from operations?

The current quarterly CFO of APGE is -$48.48M

What is the all time high quarterly CFO for Apogee Therapeutics?

Apogee Therapeutics all-time high quarterly cash flow from operations is -$10.56M

What is Apogee Therapeutics quarterly CFO year-on-year change?

Over the past year, APGE quarterly cash flow from operations has changed by -$16.84M (-53.23%)

What is Apogee Therapeutics TTM cash flow from operations?

The current TTM CFO of APGE is -$188.01M

What is the all time high TTM CFO for Apogee Therapeutics?

Apogee Therapeutics all-time high TTM cash flow from operations is -$10.56M

What is Apogee Therapeutics TTM CFO year-on-year change?

Over the past year, APGE TTM cash flow from operations has changed by -$92.17M (-96.18%)
On this page